ARDT
Ardent Health Partners

77
Mkt Cap
$1.19B
Volume
410,685.00
52W High
$15.65
52W Low
$8.22
PE Ratio
5.92
ARDT Fundamentals
Price
$8.54
Prev Close
$8.30
Open
$8.39
50D MA
$9.26
Beta
0.51
Avg. Volume
543,730.41
EPS (Annual)
$1.47
P/B
0.99
Rev/Employee
$239,601.29
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - ARDT
INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - ARDT INVESTOR ALERT: Ardent Health...
PR Newswire·10h ago
News Placeholder
More News
News Placeholder
Ardent Health (ARDT) Hit With Securities Class Action Over Alleged Accounting Deception - Hagens Berman
Ardent Health (ARDT) Hit With Securities Class Action Over Alleged Accounting Deception - Hagens Berman Ardent Health (ARDT) Hit With Securities Class Action Over Alleged Accounting Deception...
PR Newswire·11h ago
News Placeholder
Ardent Health, Inc. Class Action: Levi & Korsinsky Reminds Ardent Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 9, 2026 - ARDT
Ardent Health, Inc. Class Action: Levi & Korsinsky Reminds Ardent Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 9, 2026 - ARDT Ardent Health, Inc...
PR Newswire·21h ago
News Placeholder
Shareholders who lost money in shares of Ardent, Inc. (NYSE: ARDT) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of Ardent, Inc. (NYSE: ARDT) Should Contact Wolf Haldenstein Immediately Shareholders who lost money in shares of Ardent, Inc. (NYSE: ARDT) Should Contact Wolf...
PR Newswire·1d ago
News Placeholder
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Jan...
PR Newswire·2d ago
News Placeholder
Ardent Health (NYSE:ARDT) Hits New 52-Week Low on Analyst Downgrade
Ardent Health (NYSE:ARDT) Sets New 12-Month Low After Analyst Downgrade...
MarketBeat·2d ago
News Placeholder
Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Have Opportunity to Lead Securities...
PR Newswire·2d ago
News Placeholder
JPMorgan Chase & Co. Lowers Ardent Health (NYSE:ARDT) Price Target to $11.00
JPMorgan Chase & Co. decreased their price objective on Ardent Health from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday...
MarketBeat·2d ago
News Placeholder
ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit
ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with...
PR Newswire·3d ago
News Placeholder
Ardent Health, Inc. (NYSE:ARDT) Given Average Rating of "Hold" by Brokerages
Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have been assigned an average rating of "Hold" from the twelve brokerages that are presently covering the firm, MarketBeat reports. Two...
MarketBeat·3d ago
<
1
2
...
>

Latest ARDT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.